Objective: Cognitive impairment (CI) in Maintenance hemodialysis (MHD) is attracting increasing attention. This study aims to clarify the prevalence and risk factors for cognitive dysfunction in patients on MHD who have no history of stroke.
Methods: A total of 99 patients with no history of stroke undergoing MHD were enrolled. Global cognitive function was evaluated using the Montreal Cognitive Assessment scale. Attention and executive functions were evaluated by the Digital Span (DS) test and the Color Trail Test (CTT). The Hamilton Depression and Anxiety scales were used to assess depression and anxiety status. The effects of patient background factors, laboratory indicators, anxiety, and depression on cognitive dysfunction were examined by regression analysis.
Results: There were 69.70% of the patients had general CI, 65.65% had depression, and 57.57% had anxiety. The forward and backward DS in the cognitively impaired (CI) group were shorter than in the normal cognitive function (NCF) group (P < 0.05). Times required for CTT–I, CTT–II, and CTT II − CTT I were longer in the CI group than in the NCF group (P < 0.05). Hemoglobin levels were lower, and parathyroid hormone (PTH) and uric acid levels were higher in the CI group than in the NCF group (P < 0.05). Hemoglobin levels were negatively correlated with CI in these patients (odds ratio [OR] 0.634, P < 0.05) and PTH, and uric acid levels were positively correlated with CI (OR 1.028, P < 0.05; and OR 1.011, P < 0.05). The proportions of patients with diabetes and depression were higher in the CI group (P < 0.05).
Conclusion: There was a high prevalence of CI with significant impairment of attention and executive ability in MHD patients who had no stroke history. Hemoglobin may protect cognitive function, while diabetes, PTH, and uric acid levels may be risk factors. Depressive and anxiety states may aggravate CI in MHD patients.
Keywords: end-stage renal disease, maintenance hemodialysis, cognitive impairment, executive ability, risk factors